Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yaney, G. C.
Right arrow Articles by Boyd, A. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yaney, G. C.
Right arrow Articles by Boyd, A. E., III
Social Bookmarking
Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Diabetes 50:56-62, 2001
© 2001 by the American Diabetes Association, Inc.

Glucagon-Like Peptide 1 Stimulates Lipolysis in Clonal Pancreatic ß-Cells (HIT)

Gordon C. Yaney, Vildan N. Civelek, Ann-Marie Richard, Joseph S. Dillon, Jude T. Deeney, James A. Hamilton, Helen M. Korchak, Keith Tornheim, Barbara E. Corkey, and Aubrey E. Boyd, III

From the Obesity Research Center (G.C.Y., V.N.C., A.-M.R, J.T.D., J.A.H., K.T., B.E.C.), Evans Department of Medicine, and the Departments of Biochemistry (B.E.C., K.T.) and Biophysics (J.A.H.), Boston Medical Center, Boston, Massachusetts; the Division of Endocrinology (J.S.D.), University of Iowa School of Medicine, Iowa City, Iowa; and the Immunology Division (H.M.K.), Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.

Address correspondence and reprint requests to Dr. Barbara E. Corkey, Obesity Research Center, EBRC-808, Boston Medical Center, 650 Albany St., Boston, MA 02118. E-mail: bcorkey{at}med-med1.bu.edu .

Glucagon-like peptide 1 (GLP-1) is the most potent physiological incretin for insulin secretion from the pancreatic ß-cell, but its mechanism of action has not been established. It interacts with specific cell-surface receptors, generates cAMP, and thereby activates protein kinase A (PKA). Many changes in pancreatic ß-cell function have been attributed to PKA activation, but the contribution of each one to the secretory response is unknown. We show here for the first time that GLP-1 rapidly released free fatty acids (FFAs) from cellular stores, thereby lowering intracellular pH (pHi) and stimulating FFA oxidation in clonal ß-cells (HIT). Similar changes were observed with forskolin, suggesting that stimulation of lipolysis was a function of PKA activation in ß-cells. Triacsin C, which inhibits the conversion of FFAs to long-chain acyl CoA (LC-CoA), enhanced basal FFA efflux as well as GLP-1-induced acidification and efflux of FFAs from the cell. Increasing the concentration of the lipase inhibitor orlistat progressively and largely diminished the increment in secretion caused by forskolin. However, glucose-stimulated secretion was less inhibited by orlistat and only at the highest concentration tested. Because the acute addition of FFAs also increases glucose-stimulated insulin secretion, these data suggest that the incretin function of GLP-1 may involve a major role for lipolysis in cAMP-mediated potentiation of secretion.


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 DiabetesHome page
M. Fex, S. Lucas, M. S. Winzell, B. Ahren, C. Holm, and H. Mulder
{beta}-Cell Lipases and Insulin Secretion
Diabetes, December 1, 2006; 55(Supplement_2): S24 - S31.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
F. F. Dai, Y. Zhang, Y. Kang, Q. Wang, H. Y. Gaisano, K.-H. Braunewell, C. B. Chan, and M. B. Wheeler
The Neuronal Ca2+ Sensor Protein Visinin-like Protein-1 Is Expressed in Pancreatic Islets and Regulates Insulin Secretion
J. Biol. Chem., August 4, 2006; 281(31): 21942 - 21953.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
L. Hu, J. T. Deeney, C. J. Nolan, M.-L. Peyot, A. Ao, A. M. Richard, E. Luc, N. J. Faergeman, J. Knudsen, W. Guo, et al.
Regulation of lipolytic activity by long-chain acyl-coenzyme A in islets and adipocytes
Am J Physiol Endocrinol Metab, December 1, 2005; 289(6): E1085 - E1092.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
P. Thams, M. R Anwar, and K. Capito
Glucose triggers protein kinase A-dependent insulin secretion in mouse pancreatic islets through activation of the K+ATP channel-dependent pathway
Eur. J. Endocrinol., April 1, 2005; 152(4): 671 - 677.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
M. Fex, C. S. Olofsson, U. Fransson, K. Bacos, H. Lindvall, M. Sorhede-Winzell, P. Rorsman, C. Holm, and H. Mulder
Hormone-Sensitive Lipase Deficiency in Mouse Islets Abolishes Neutral Cholesterol Ester Hydrolase Activity but Leaves Lipolysis, Acylglycerides, Fat Oxidation, and Insulin Secretion Intact
Endocrinology, August 1, 2004; 145(8): 3746 - 3753.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
M.-L. Peyot, C. J. Nolan, K. Soni, E. Joly, R. Lussier, B. E. Corkey, S. P. Wang, G. A. Mitchell, and M. Prentki
Hormone-Sensitive Lipase Has a Role in Lipid Signaling for Insulin Secretion but Is Nonessential for the Incretin Action of Glucagon-Like Peptide 1
Diabetes, July 1, 2004; 53(7): 1733 - 1742.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
G. G. Holz
Epac: A New cAMP-Binding Protein in Support of Glucagon-Like Peptide-1 Receptor-Mediated Signal Transduction in the Pancreatic {beta}-Cell
Diabetes, January 1, 2004; 53(1): 5 - 13.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
H. Mulder, S. Yang, M. S. Winzell, C. Holm, and B. Ahren
Inhibition of Lipase Activity and Lipolysis in Rat Islets Reduces Insulin Secretion
Diabetes, January 1, 2004; 53(1): 122 - 128.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
H. Mulder, M. Sorhede-Winzell, J. A. Contreras, M. Fex, K. Strom, T. Ploug, H. Galbo, P. Arner, C. Lundberg, F. Sundler, et al.
Hormone-sensitive Lipase Null Mice Exhibit Signs of Impaired Insulin Sensitivity whereas Insulin Secretion Is Intact
J. Biol. Chem., September 19, 2003; 278(38): 36380 - 36388.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
P. E. MacDonald, W. El-kholy, M. J. Riedel, A. M. F. Salapatek, P. E. Light, and M. B. Wheeler
The Multiple Actions of GLP-1 on the Process of Glucose-Stimulated Insulin Secretion
Diabetes, December 1, 2002; 51(90003): S434 - 442.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
O. G. Chepurny, M. A. Hussain, and G. G. Holz
Exendin-4 as a Stimulator of Rat Insulin I Gene Promoter Activity via bZIP/CRE Interactions Sensitive to Serine/Threonine Protein Kinase Inhibitor Ro 31-8220
Endocrinology, June 1, 2002; 143(6): 2303 - 2313.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
M. C. Lawrence, H. S. Bhatt, and R. A. Easom
NFAT Regulates Insulin Gene Promoter Activity in Response to Synergistic Pathways Induced by Glucose and Glucagon-Like Peptide-1
Diabetes, March 1, 2002; 51(3): 691 - 698.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
R. Roduit, P. Masiello, S. P. Wang, H. Li, G. A. Mitchell, and M. Prentki
A Role for Hormone-Sensitive Lipase in Glucose-Stimulated Insulin Secretion: A Study in Hormone-Sensitive Lipase-Deficient Mice
Diabetes, September 1, 2001; 50(9): 1970 - 1975.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2001 by the American Diabetes Association.